Literature DB >> 9406003

Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer.

I Romics1, D Frang, I Bodrogi.   

Abstract

Authors investigated PSA concentration and preoperative prostate volume in 113 histologically proved BPH and 31 prostatic cancer patients. PSA concentration was measured with the Hybritech kit, the prostate volume by ultrasound with the help of an ellipse and calculated by computer. There was no correlation between the age of patients and volume of the prostate, whereas a correlation was proved between marker concentration and prostate volume (p < 0.0001). The difference obtained by the correlation of the prostate volume and the PSA concentration ratio between the BPH and 31 tumorous patients (PSA density) was highly significant (0.143 vs. 0.699, p < 0.001). The use of PSAD further improves the diagnostic value of PSA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406003     DOI: 10.1007/bf02551112

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

Review 1.  What's new in tumor markers for prostate cancer?

Authors:  T M Chu; G P Murphy
Journal:  Urology       Date:  1986-06       Impact factor: 2.649

Review 2.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

3.  [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].

Authors:  A Semjonow; M Hamm; P Rathert
Journal:  Urologe A       Date:  1993-05       Impact factor: 0.639

4.  Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen.

Authors:  P H Walz; T Schoppmann; C Büscher; J Ennen; H Schriewer
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

5.  Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.

Authors:  H B Carter; C H Morrell; J D Pearson; L J Brant; C C Plato; E J Metter; D W Chan; J L Fozard; P C Walsh
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

6.  The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

Authors:  M C Benson; I S Whang; C A Olsson; D J McMahon; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

7.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

8.  Prostate-specific antigen density: a means to enhance detection of prostate cancer.

Authors:  J Ramon; L Boccon-Gibod; T Billebaud; L Astier; M Kobelinsky; A Meulemans; M C Dauge; L Boccon-Gibod; A Villers
Journal:  Eur Urol       Date:  1994       Impact factor: 20.096

9.  Differentiation of benign prostatic hyperplasia and prostate cancer employing prostatic-specific antigen density.

Authors:  J M Wolff; A Scholz; W Boeckmann; G Jakse
Journal:  Eur Urol       Date:  1994       Impact factor: 20.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.